Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone PK/PD in pediatric graft-versus-host disease after hematopoietic cell transplantation
NL-OMON54530Recruiting
- Sponsor
- Princess Máxima Center for Pediatric Oncology
- Start
- Sep 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of prednisolone in graft-versus-host disease (GVHD), sponsored by Princess Máxima Center for Pediatric Oncology. Primary endpoint: Prednisolone pharmacokinetic parameters. Started Sep 2020; status: recruiting.
02
Drugs
prednisolone
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NL-OMON54530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54530.